Cardax Pharmaceuticals becomes Hawaii’s 16th publicly-traded company
February 07, 2014 at 17:36 PM EST
Cardax Pharmaceuticals, a Hawaii-based life sciences company that is developing safe, anti-inflammatory drugs to combat chronic illnesses such as rheumatoid arthritis, cardiovascular disease and diabetes, said Friday that it is officially a public company after completing a reverse merger with a publicly-traded Houston coffee-roasting firm...